FDA Adverse Event
Injury
Summary report: N
DIASORIN LIASON XL HSV 1
MDR report key: 16753352
·
Received April 14, 2023
Report
- Report Number
- MW5116708
- Event Type
- Injury
- Date Received
- April 14, 2023
- Date of Event
- June 22, 2022
- Report Date
- April 12, 2023
- Manufacturer
- DIASORIN INC.
- Product Code
- MXJ
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- OR, US
- Reporter Occupation
- 117
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
PATIENT HAD A HSV 2 POSITIVE TEST ON THE DIASORIN HSV 1 AND 2 IGG TEST, (INDEX VALUE = 1.27), FOLLOWED UP WITH A WESTERN BLOT WHICH WAS NEGATIVE FOR HSV 2. DATE GIVEN IS THE WESTERN BLOT CONFIRMATORY TEST.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1597951 | DIASORIN LIASON XL HSV 1 | ENZYME LINKED IMMUNOSORBENT ASSAY, HERPES SIMPLEX VIRUS, HSV-1 | MXJ | DIASORIN INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 25 YR | Female | Other |